AI assistant
AbbVie Inc. — Director's Dealing 2025
Mar 10, 2025
29755_dirs_2025-03-10_75481ec7-74d9-40ee-80fe-6bb5e48874b8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2025-03-01
Reporting Person: Purdue David Ryan (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $0.01 par value | 4505 | Direct |
| Common Stock, $0.01 par value | 527 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option (Right to buy) | $149.62 | 2033-02-15 | Common Stock (3376) | Direct | |
| Option (Right to buy) | $175.28 | 2034-02-14 | Common Stock (5358) | Direct | |
| Option (Right to buy) | $192.86 | 2035-02-12 | Common Stock (5208) | Direct |
Footnotes
F1: Balance in AbbVie Savings Program as of March 1, 2025. Balance includes shares acquired pursuant to a dividend reinvestment feature.
F2: Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program. The option became exercisable as to 1,126 shares on 02/16/2024, as to 1,125 shares on 02/16/2025, and will become exercisable as to 1,125 shares on 02/16/2026.
F3: Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program. The option became exercisable as to 1,786 shares on 02/15/2025, and will become exercisable as to 1,786 shares on 02/15/2026, and as to 1,786 shares on 02/15/2027.
F4: Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program. The option becomes exercisable as to 1,736 shares on 02/13/2026, as to 1,736 shares on 02/13/2027, and as to 1,736 shares on 02/13/2028.